Fresenius Medical Care | FME - Cash And Equivalent


Fresenius Medical Care reported EUR1.24B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Akzo Nobel EUR 2.76B 1.14B Mar/2026
Alcon AG USD 1.58B 80M Mar/2026
AstraZeneca USD 4.89B 2.67B Jun/2026
Bayer EUR 5.73B 943M Mar/2026
Beiersdorf EUR 1.2B 33M Dec/2025
DaVita Healthcare Partners USD 668.96M 24.72M Jun/2026
Demant DKK 1.33B 188M Dec/2025
E.ON EUR 4.87B 1.83B Mar/2026
Essilor EUR 3.54B 758M Dec/2025
Fresenius EUR 2.06B 752M Mar/2026
Fresenius Medical Care EUR 1.24B 343.37M Mar/2026
Genmab DKK 1.5B 18M Jun/2026
Getinge SEK 2.05B 909M Jun/2026
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.44B 292M Mar/2026
GN Store Nord DKK 1.12B 352M Dec/2025
GRIFOLS EUR 513M 189M Jun/2026
Hikma Pharmaceutical USD 217M 19M Dec/2025
Lonza CHF 719M 188M Dec/2025
Merck EUR 2.74B 415M Mar/2026
Novartis USD 7.62B 739M Jun/2026
Philips EUR 1.79B 803M Jun/2026
Roche Holding CHF 7.55B 579M Jun/2025
RWE EUR 7.73B 4.68B Dec/2025
Sanofi EUR 6.35B 806M Jun/2026
SAP EUR 10.04B 1.83B Mar/2026